Skip to content
AnalystLens

PROCTER & GAMBLE Co Quarterly Report for Q1 Ended Sep 30, 2020

Filing Date
Filed October 20, 2020
Period End
September 30, 2020
Security
PG
One revenue dollarkept$0.22
In the record · 2016–202610-K1210-Q328-K224

PG filed 12 annual reports (10-K), 32 quarterly reports (10-Q) and 224 current reports (8-K) between 2016 and 2026.

  1. Leadership change8-K · Apr ’22Apr ’22
  2. Leadership change8-K · Jul ’26Jul ’26

Summary

Summary of the 10-Q filed October 20, 2020. Cited figures are marked; the original filing is the authoritative source.

Procter & Gamble (PG) reported strong performance for the first quarter of fiscal year 2021, with net sales increasing by 9% year-over-year to $19.3 billiona.

This growth was driven by a 7% increase in unit volume, supported by a mid-teen increase in Fabric & Home Care, and double-digit growth in Health Care, demonstrating resilience and consumer demand for essential products. Net earnings attributable to P&G surged by 19% to $4.3 billionb, translating to a 20% increase in diluted Earnings Per Share (EPS) to $1.63. The company highlighted the positive impact of the COVID-19 pandemic on demand for certain product categories, such as fabric, home cleaning, and hygiene products, while also noting some slowdowns in beauty and grooming categories due to economic conditions and consumer movement restrictions in specific regions.

Operationally, P&G achieved significant gross margin expansion, up 170 basis points to 52.7%, benefiting from manufacturing cost savings and lower commodity costs. Selling, general, and administrative (SG&A) expenses as a percentage of sales decreased, indicating improved operational leverage. The company also reported robust operating cash flow of $4.7 billionc and adjusted free cash flow of $4.1 billion, with a strong productivity of 95%.

Management's outlook suggests continued focus on productivity and cost savings, with expectations for fiscal year 2021 restructuring costs to be within the historical ongoing range. The company also announced plans to retire approximately $2.3 billiond of outstanding debt securities, underscoring a commitment to financial discipline.

Key Highlights

  1. Net sales increased by 9% to $19.3 billion, driven by a 7% increase in unit volume, with notable strength in Fabric & Home Care and Health Care segments.
  2. Net earnings attributable to P&G rose by 19% to $4.3 billion, with diluted EPS growing 20% to $1.63.
  3. Gross margin improved by 170 basis points to 52.7%, supported by manufacturing cost savings and lower commodity costs.
  4. Operating cash flow was strong at $4.7 billion, and adjusted free cash flow reached $4.1 billion with 95% productivity.
  5. The COVID-19 pandemic positively impacted demand for essential products like cleaning and hygiene items, while affecting beauty and grooming categories in certain regions.
  6. The company plans to reduce outstanding shares through repurchases of $7 to $9 billion in fiscal year 2021.
  7. P&G announced a plan to early retire approximately $2.3 billion of outstanding debt securities.

Follow one dollar

Of each $1.00 of revenue in Q1 FY2021, Procter & Gamble Co kept $0.22.

  1. Revenue$19.32B100.0%
  2. Cost of revenue−$9.14B47.3%
  3. Gross profit$10.18B52.7%
  4. Operating costs−$4.89B25.3%
  5. Operating income$5.28B27.3%
  6. Interest, other & tax−$973.0M5.0%
  7. Net income$4.31B22.3%
Computed from 10-QQ1 FY2021filed October 20, 2020Computed from this filing’s revenue, gross profit, operating income and net income · right columngrey figure: share of revenue

Financial Statements

Q1 FY2021 against Q1 FY2020

Line itemQ1 FY2021Q1 FY2020Change
Revenue$19.32B$17.80B+8.5%
Cost of Revenue$9.14B$8.72B+4.8%
Gross Profit$10.18B$9.07B+12.1%
SG&A Expenses$4.89B$4.79B+2.3%
Operating Income$5.28B$4.29B+23.1%
Interest Expense$136.00M$108.00M+25.9%
Net Income$4.31B$3.59B+19.9%
EPS (Basic)$1.69$1.41+19.9%
EPS (Diluted)$1.63$1.36+19.9%
Shares Outstanding (Basic)2.49B2.50B−0.7%
Shares Outstanding (Diluted)2.63B2.65B−0.8%

Frequently Asked Questions

  1. How did the COVID-19 pandemic impact P&G's financial performance in this quarter?

    The COVID-19 pandemic had mixed impacts. It significantly increased demand for essential product categories like fabric care, home cleaning, and personal hygiene products, leading to sales growth, particularly in North America and Europe. However, it also led to decreased sales in certain beauty and grooming products and experienced economic slowdowns and restricted consumer movements in regions like IMEA, Asia Pacific, and Latin America.

  2. What drove the increase in net sales and earnings?

    Net sales increased by 9% driven by a 7% rise in unit volume, favorable pricing, and mix effects, with strong performance across most segments. Net earnings increased by 19% due to higher net sales, improved operating margins resulting from manufacturing cost savings and reduced SG&A expenses, partially offset by a higher effective tax rate.

  3. What is the company's strategy regarding debt and shareholder returns?

    P&G demonstrated strong cash generation, with robust operating cash flow and adjusted free cash flow. The company plans to repurchase $7 to $9 billion of shares in fiscal year 2021 and has announced a plan to retire approximately $2.3 billion of outstanding debt securities, indicating a focus on financial deleveraging and returning capital to shareholders.

  4. Are there any significant risks related to the company's intangible assets?

    The company identifies the Gillette indefinite-lived intangible asset as most susceptible to future impairment risk. While management's current assessment indicates no impairment, significant uncertainty remains regarding the duration and impact of the COVID-19 pandemic, which could negatively affect sales and earnings growth assumptions used in impairment testing, potentially leading to future impairment charges if conditions worsen.